Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-23T10:11:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays an updated site revision number, from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-16T09:51:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-09T10:27:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message, preventing access to the trial details.
    Difference
    0.5%
    Check dated 2026-10-02T11:17:48.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Deletions remove sponsor/partner names (Muscular Dystrophy Association, CureSMA, SMA Europe, Biogen), study documents (PDFs including the Statistical Analysis Plan and Study Protocol), IPD sharing details, and location-related text (e.g., 'Study website - US patients only' and listing of study sites), reducing visibility of collaborators, documents, and geographic sites.
    Difference
    23%
    Check dated 2026-09-25T09:24:51.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, indicating a software/feature update to the site’s underlying platform. This change appears to affect only the software version label and does not alter study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-09-18T10:29:36.000Z thumbnail image

Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.